Lara Batey1, Jennifer E Moon, Yongguo Yu, Bingbing Wu, Joel N Hirschhorn, Yiping Shen, Andrew Dauber. 1. Division of Endocrinology (L.B., J.E.M., J.N.H., A.D.), Boston Children's Hospital, Boston, Massachusetts 02115; Shanghai Children's Medical Center (Y.Y.), Shanghai Jiaotong University School of Medicine, Shanghai 200127, China; Pediatrics Institute (B.W.), Key Laboratory of Neonatal Diseases, Ministry of Health, Children's Hospital of Fudan University, Shanghai 201102, PR China; Program in Medical and Population Genetics (J.N.H.), Broad Institute, Cambridge, Massachusetts 02142; Department of Genetics (J.N.H.), Harvard Medical School, Boston, Massachusetts 02115; Department of Pathology (Y.S.), Harvard Medical School, and Department of Laboratory Medicine, Boston Children's Hospital, Boston, Massachusetts 02115; and Shanghai Children's Medical Center (Y.S.), Shanghai Jiaotong University School of Medicine, Shanghai 200127, China.
Abstract
CONTEXT: Short stature is a common reason for referral to pediatric endocrinology centers. Frequently, the underlying etiology of short stature is unknown, resulting in a diagnosis of idiopathic short stature. Rare genetic defects in the GH/IGF-1 axis have been found to cause short stature. OBJECTIVE: The objective of this study was to identify the genetic etiology of short stature in a patient with Idiopathic Short Stature and to review the clinical presentation of patients with genetic defects in IGF1, and specifically IGF-1 haploinsufficiency. DESIGN/SETTING/PARTICIPANTS: The index patient was evaluated at an academic medical center, and DNA was obtained from the proband and both parents. INTERVENTION: Genome-wide copy number analysis was performed in the proband with confirmatory quantitative PCR in the proband and his parents. MAIN OUTCOME MEASURE: We measured novel copy number variants (CNVs) thought to explain the patient's short stature. RESULTS: CNV analysis revealed that the proband carried a paternally inherited heterozygous IGF1 gene deletion. His phenotypic features are consistent with those found in previous case reports of IGF-1 deficiency. CONCLUSIONS: This study, as the first case of a complete heterozygous 1GF1 deletion, provides insight into the effects of true IGF-1 haploinsufficiency. Given the similarities in phenotype between the present proband and those previously described, it is highly likely that his IGF1 deletion is the cause for his short stature. Broadly, this study emphasizes how CNV analysis and other genetic sequencing techniques are evolving as an important tool to identify genetic causes underlying human disease, allowing for improved diagnosis and targeted treatment.
CONTEXT: Short stature is a common reason for referral to pediatric endocrinology centers. Frequently, the underlying etiology of short stature is unknown, resulting in a diagnosis of idiopathic short stature. Rare genetic defects in the GH/IGF-1 axis have been found to cause short stature. OBJECTIVE: The objective of this study was to identify the genetic etiology of short stature in a patient with Idiopathic Short Stature and to review the clinical presentation of patients with genetic defects in IGF1, and specifically IGF-1haploinsufficiency. DESIGN/SETTING/PARTICIPANTS: The index patient was evaluated at an academic medical center, and DNA was obtained from the proband and both parents. INTERVENTION: Genome-wide copy number analysis was performed in the proband with confirmatory quantitative PCR in the proband and his parents. MAIN OUTCOME MEASURE: We measured novel copy number variants (CNVs) thought to explain the patient's short stature. RESULTS: CNV analysis revealed that the proband carried a paternally inherited heterozygous IGF1 gene deletion. His phenotypic features are consistent with those found in previous case reports of IGF-1 deficiency. CONCLUSIONS: This study, as the first case of a complete heterozygous 1GF1 deletion, provides insight into the effects of true IGF-1haploinsufficiency. Given the similarities in phenotype between the present proband and those previously described, it is highly likely that his IGF1 deletion is the cause for his short stature. Broadly, this study emphasizes how CNV analysis and other genetic sequencing techniques are evolving as an important tool to identify genetic causes underlying human disease, allowing for improved diagnosis and targeted treatment.
Authors: Andrew Dauber; Yongguo Yu; Michael C Turchin; Charleston W Chiang; Yan A Meng; Ellen W Demerath; Sanjay R Patel; Stephen S Rich; Jerome I Rotter; Pamela J Schreiner; James G Wilson; Yiping Shen; Bai-Lin Wu; Joel N Hirschhorn Journal: Am J Hum Genet Date: 2011-11-23 Impact factor: 11.025
Authors: M J E Walenkamp; M Karperien; A M Pereira; Y Hilhorst-Hofstee; J van Doorn; J W Chen; S Mohan; A Denley; B Forbes; H A van Duyvenvoorde; S W van Thiel; C A Sluimers; J J Bax; J A P M de Laat; M B Breuning; J A Romijn; J M Wit Journal: J Clin Endocrinol Metab Date: 2005-03-15 Impact factor: 5.958
Authors: C Camacho-Hübner; K A Woods; F Miraki-Moud; P C Hindmarsh; A J Clark; Y Hansson; A Johnston; R C Baxter; M O Savage Journal: J Clin Endocrinol Metab Date: 1999-05 Impact factor: 5.958
Authors: H A van Duyvenvoorde; P A van Setten; M J E Walenkamp; J van Doorn; J Koenig; L Gauguin; W Oostdijk; C A L Ruivenkamp; M Losekoot; J D Wade; P De Meyts; M Karperien; C Noordam; J M Wit Journal: J Clin Endocrinol Metab Date: 2010-07-28 Impact factor: 5.958
Authors: Alessia David; Vivian Hwa; Louise A Metherell; Irène Netchine; Cecilia Camacho-Hübner; Adrian J L Clark; Ron G Rosenfeld; Martin O Savage Journal: Endocr Rev Date: 2011-04-27 Impact factor: 19.871
Authors: Helen L Storr; Sumana Chatterjee; Louise A Metherell; Corinne Foley; Ron G Rosenfeld; Philippe F Backeljauw; Andrew Dauber; Martin O Savage; Vivian Hwa Journal: Endocr Rev Date: 2019-04-01 Impact factor: 19.871
Authors: Owen G Davies; Yang Liu; Darren J Player; Neil R W Martin; Liam M Grover; Mark P Lewis Journal: Front Physiol Date: 2017-04-03 Impact factor: 4.566
Authors: Jonathon N Winnay; Marie H Solheim; Ercument Dirice; Masaji Sakaguchi; Hye-Lim Noh; Hee Joon Kang; Hirokazu Takahashi; Kishan K Chudasama; Jason K Kim; Anders Molven; C Ronald Kahn; Pål R Njølstad Journal: J Clin Invest Date: 2016-03-14 Impact factor: 14.808